Olivier Casasnovas
AuthID: R-00F-J6W
1
TÃTULO: Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.
AUTORES: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...Mais
PUBLICAÇÃO: 2010, FONTE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, NÚMERO: 21
AUTORES: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...Mais
PUBLICAÇÃO: 2010, FONTE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, NÚMERO: 21
INDEXADO EM: 
WOS
WOS